KR900005963A - Formulations for the supply of iron, preparations for the supply of vitamins, and methods of stabilizing foamed preparations - Google Patents

Formulations for the supply of iron, preparations for the supply of vitamins, and methods of stabilizing foamed preparations Download PDF

Info

Publication number
KR900005963A
KR900005963A KR1019890014192A KR890014192A KR900005963A KR 900005963 A KR900005963 A KR 900005963A KR 1019890014192 A KR1019890014192 A KR 1019890014192A KR 890014192 A KR890014192 A KR 890014192A KR 900005963 A KR900005963 A KR 900005963A
Authority
KR
South Korea
Prior art keywords
weight
iron
range
addition amount
sodium
Prior art date
Application number
KR1019890014192A
Other languages
Korean (ko)
Other versions
KR0143232B1 (en
Inventor
아끼히사 다까이찌
도시히꼬 오까모또
도시아끼 마쭈모또
Original Assignee
원본미기재
오쯔까 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 오쯔까 세이야꾸 가부시끼가이샤 filed Critical 원본미기재
Publication of KR900005963A publication Critical patent/KR900005963A/en
Application granted granted Critical
Publication of KR0143232B1 publication Critical patent/KR0143232B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

내용 없음No content

Description

철 공급용 제제, 비타민 공급용 제제, 및 발포 제제의 안정화 방법Formulations for the supply of iron, preparations for the supply of vitamins, and methods of stabilizing foamed preparations

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (25)

필수성분으로서, 시트로산철 암모늄, 시트르산 제일철나트륨 및 시트르산철로 이루어진 그룹중에서 선택된 하나 이상의 철-함유 화합물 0.01 내지 3.5중량%(이는 철로 환산된 양을 기준으로 한 것이다), 탄산나트륨 및/또는 탄산수소나트륨 10 내지 35중량%, 및 중화제 20 내지 70중량%를 함유함을 특징으로 하는 철 공급용 제제.As essential ingredients 0.01 to 3.5% by weight of one or more iron-containing compounds selected from the group consisting of ammonium ferric citrate, sodium ferric citrate and iron citrate (based on amounts in iron), sodium carbonate and / or sodium bicarbonate 10 to 35% by weight, and 20 to 70% by weight neutralizing agent. 제1항에 있어서, 철-함유 화합물의 부가량이 0.06 내지 0.6중량%인 철 공급용 제제.The iron supply preparation according to claim 1, wherein the addition amount of the iron-containing compound is 0.06 to 0.6 wt%. 제1항에 있어서, 철-함유 화합물이 시트로산철 암모늄인 철 공급용 제제.2. The iron supply formulation of claim 1, wherein the iron-containing compound is iron ammonium citrate. 제3항에 있어서, 시트르산철 암모늄의 부가량이 0.6 내지 1.8중량%의 범위인 철 공급용 제제.The iron supply preparation according to claim 3, wherein the addition amount of ammonium iron citrate is in the range of 0.6 to 1.8% by weight. 제1항에 있어서, 시트르산제일철 나트륨의 부가량이 0.6 내지 3중량%의 범위인 철 공급용 제제.The iron supply preparation according to claim 1, wherein the addition amount of ferrous citrate sodium is in the range of 0.6 to 3% by weight. 제5항에 있어서, 시트르산 철의 부가량이 0.4 내지 1.8중량%의 범위인 철 공급용 제제.The iron supply preparation according to claim 5, wherein the addition amount of iron citrate is in the range of 0.4 to 1.8% by weight. 제1항에 있어서, 탄산나트륨의 부가량이 11 내지 31중량%의 범위인 철 공급용 제제.The iron supply preparation according to claim 1, wherein the addition amount of sodium carbonate is in the range of 11 to 31% by weight. 제7항에 있어서, 탄산나트륨의 부가량이 22 내지 26중량%의 범위인 철 공급용 제제.8. The iron supply preparation according to claim 7, wherein the addition amount of sodium carbonate is in the range of 22 to 26% by weight. 제1항에 있어서, 탄산수소나트륨의 부가량이 10 내지 35중량%의 범위인 철 공급용 제제.The preparation for iron supply of Claim 1 in which the addition amount of sodium hydrogencarbonate is in the range of 10 to 35 weight%. 제9항에 있어서, 탄산수소나트륨의 부가량이 20내지 30중량%의 범위인 철 공급용 제제.The iron supply preparation according to claim 9, wherein the addition amount of sodium hydrogencarbonate is in the range of 20 to 30% by weight. 제10항에 있어서, 탄산수소나트륨이 20 내지 25중량%의 범위에서 단독으로 부가되는 철 공급용 제제.The iron supply preparation according to claim 10, wherein sodium bicarbonate is added alone in a range of 20 to 25% by weight. 제10항에 있어서, 중화제가 탄산나트륨 및/또는 탄화수소나트륨을 중화시켜 탄산기체를 발생시키는 산화합물인 철 공급용 제제.The iron supply preparation according to claim 10, wherein the neutralizing agent is an acid compound which neutralizes sodium carbonate and / or sodium hydrocarbon to generate a carbonate gas. 제11항에 있어서, 중화제의 부가량이 30 내지 40중량%의 범위인 철 공급용 제제.The preparation for iron supply according to claim 11, wherein the addition amount of the neutralizing agent is in the range of 30 to 40% by weight. 제11항에 있어서, 중화제가 아스코르브산 및 L-타르타르산을 포함하는 철 공급용 제제.The formulation for iron supply according to claim 11, wherein the neutralizing agent comprises ascorbic acid and L-tartaric acid. 제14항에 있어서, 아스코르브산 및 L-타르타르산의 부가량이 각각 8 내지 22중량% 및 18 내지 25중량%의 범위인 철 공급용 제제.The preparation for iron supply according to claim 14, wherein the addition amount of ascorbic acid and L-tartaric acid is in the range of 8 to 22% by weight and 18 to 25% by weight, respectively. 제1항에 있어서, 물에 용해시켜 수득한 용액의 pH가 3.5 내지 4.6인 철 공급용 제제.The preparation for iron supply according to claim 1, wherein the pH of the solution obtained by dissolving in water is 3.5 to 4.6. 필수성분으로서, 철-함유 화합물, 탄산나트륨 및/또는 탄산수소나트륨, 중화제, 및 저장 안정화제인 탄산칼륨을 함유함을 특징으로 하는 철 공급용 제제.An essential ingredient comprising an iron-containing compound, sodium carbonate and / or sodium bicarbonate, a neutralizing agent, and potassium carbonate as a storage stabilizer. 제17항에 있어서, 철-함유 화합물 0.10 내지 3.5중량%(이는 철로 환산된 양을 기준으로 한 것이다), 탄산나트륨 및/또는 탄산수소나트륨 10 내지 35중량%, 중화제 20 내지 70중량%, 및 탄산칼륨 0.2 내지 13중량%를 함유하는 철 공급용 제제.18. The method according to claim 17, wherein the iron-containing compound is present in an amount of 0.10 to 3.5% by weight (based on the amount in terms of iron), sodium carbonate and / or sodium hydrogen carbonate, 10 to 35% by weight, neutralizer 20 to 70% by weight, and carbonic acid. Formulation for iron supply containing 0.2 to 13% by weight of potassium. 제18항에 있어서, 탄산칼륨의 부가량이 0.3 내지 3중량%의 범위인 철 공급용 제제.19. The iron supply preparation according to claim 18, wherein the addition amount of potassium carbonate is in the range of 0.3 to 3% by weight. 제19항에 있어서, 탄산칼륨의 부가량이 0.4 내지 1중량%의 범위인 철 공급용 제제.20. The iron supply preparation according to claim 19, wherein the addition amount of potassium carbonate is in the range of 0.4 to 1% by weight. 비타민 C, 탄산나트륨 또는 탄산수소나트륨 및 중화제를 함유하는 비타민 공급용 제제에 있어서, 저장 안정화제로서 탄산칼륨이 부가됨을 특징으로 하는 제제.A vitamin supply formulation containing vitamin C, sodium carbonate or sodium bicarbonate, and a neutralizing agent, wherein potassium carbonate is added as a storage stabilizer. 제21항에 있어서, 탄산칼륨의 부가량이 0.2 내지 13중량%의 범위인 비타민 공급용 제제.The preparation for supplying vitamins according to claim 21, wherein the addition amount of potassium carbonate is in the range of 0.2 to 13% by weight. 제22항에 있어서, 탄산수소나트륨의 부가량이 0.3 내지 3중량%의 범위인 비타민 공급용 제제.23. A vitamin supplying preparation according to claim 22, wherein the added amount of sodium bicarbonate is in the range of 0.3 to 3% by weight. 제23항에 있어서, 탄산칼륨의 부가량이 0.4 내지 1중량%의 범위인 비타민 공급용 제제.The preparation for supplying vitamins according to claim 23, wherein the addition amount of potassium carbonate is in the range of 0.4 to 1% by weight. 탄산나트륨 또는 탄산수소나트륨 및 중화제를 함유하는 발포제제에 저장 안정화제로서 탄산칼륨을 가한 후, 발포제제를 저장함을 특징으로 하여, 발포제제를 안정화시키는 방법.A method for stabilizing a foaming agent, characterized by adding potassium carbonate as a storage stabilizer to a foaming agent containing sodium carbonate or sodium bicarbonate and a neutralizing agent, and then storing the foaming agent. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890014192A 1988-10-04 1989-10-04 Preparation for iron supply, preparation for vitamin supply and method for stabilizing a foam preparation KR0143232B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP25066388 1988-10-04
JP250663/88 1988-10-04
JP63-250663 1988-10-04
JP63-306272 1988-12-02
JP306272/88 1988-12-02
JP63306272A JPH02191223A (en) 1988-10-04 1988-12-02 Iron-supplying preparation

Publications (2)

Publication Number Publication Date
KR900005963A true KR900005963A (en) 1990-05-07
KR0143232B1 KR0143232B1 (en) 1998-07-15

Family

ID=17211197

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890014192A KR0143232B1 (en) 1988-10-04 1989-10-04 Preparation for iron supply, preparation for vitamin supply and method for stabilizing a foam preparation

Country Status (2)

Country Link
JP (1) JPH02191223A (en)
KR (1) KR0143232B1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4982913B2 (en) * 2000-09-04 2012-07-25 大正製薬株式会社 Iron compound combination oral solution
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
BR0314916A (en) 2002-10-25 2005-08-16 Foamix Ltd Pharmaceutical and Cosmetic Foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Also Published As

Publication number Publication date
JPH02191223A (en) 1990-07-27
JPH0559090B2 (en) 1993-08-30
KR0143232B1 (en) 1998-07-15

Similar Documents

Publication Publication Date Title
KR900005963A (en) Formulations for the supply of iron, preparations for the supply of vitamins, and methods of stabilizing foamed preparations
US4650667A (en) Gas-emitting bath additive composition
WO2001016267A8 (en) Foaming effervescent bath product
NO952120L (en) Stabilized liquid enzymatic mixtures
EP0165656A3 (en) Improved stability oxygen scavenger compositions and method of use thereof
MY109531A (en) Effervescent antacid
GB1549038A (en) Fluorocarbon emulsions capable of carrying oxygen
KR920702324A (en) Stabilized hydrogen peroxide
IE41052B1 (en) Crop protection composition and method of application, whereby the drift of spraying liquids may be reduced
JPS5585511A (en) Permanent wave composition
JPS5631492A (en) Stabilization of residual chlorine
JPS6245516A (en) Foamable bathing agent
EP0150250B1 (en) Gas-emitting bath additive composition
US5318776A (en) Composition for preventing graying of the hair
JPH04364118A (en) Aerosol cosmetic
JPS61243014A (en) Foaming bath agent
JPS5576814A (en) Preservative solution for organ transplant
JP2000203813A (en) Hydrogen peroxide-containing aqueous liquid and stabilization of hydrogen peroxide
JPS6245515A (en) Bathing agent
JPS57153053A (en) Stable dye composition
JPH03112922A (en) Foamable bathing agent for inhibiting floating of fumaric acid
JP3913918B2 (en) Bath agent composition
JPS5714587A (en) Stabilizing method of ascorbic acid
CH610184A5 (en) Systemic fungicidal and insecticidal composition
JPH0510398B2 (en)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100323

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee